New reckoning for WHO vaccine plan as govts go it alone. South Korea doctors' strike escalates, how will cities transform post pandemic, and other pandemic-related news across the globe
European Commission president said her team could face a reshuffle after the resignation of the Irish trade commissioner over a controversy involving his questionable adherence to Covid-19 rules
The European Commission has given its go-ahead to the acquisition of the rail business of Canadian engineering firm Bombardier by French train maker Alstom
The EU has expedited the authorisation, approving the drug in an exceptionally short timeframe
Cases in US cross two million as infections rise in at least 20 states, Amazon, Ebay ordered to stop shipping unproven Covid products
Airlines including Air France-KLM and the main U.S. carriers have all sought government aid to ride out the coronavirus crisis, which has brought air travel to a near-halt.
Lagarde said the actual outcome would be between the "medium and "severe" scenarios
PE, VC funds domiciled in the island nation on the radar
The decision will make them one-third cheaper. For ventilators, the average value-added tax rate is 20%
Britain is due to leave the European Union on January 31, but will remain in a transitional arrangement until the end of the year while negotiators debate future trade ties.
The prime minister pointed out that India-EU partnership is based on shared values such as democracy, respect for rule of law, multilateralism, rules-based trade and international order.
'The question of granting an extension, that looks very good,' EU president-elect Ursula von der Leyen said
Ireland also challenges European Commission's crackdown on sweetheart deals to multinationals.
Competition Commissioner Margrethe Vestager said the issue needed addressing on competition grounds
The efforts are exacerbating the already heightened strain between the United States and Europe over a White House plan to impose stiff tariffs on most steel and aluminum imports
The Commission said divestments offered by Bayer so far did not go far enough